-
Oct 1, 2024 | 
medrxiv.org | Evangelos Oikonomou |Rohan Khera
V.S. is a coinventor of 63/346, 610 and 63/484,426, and a co-founder of Ensight-AI, Inc. E.K.O. is an academic co-founder of Evidence2Health LLC, a co-inventor in patent applications (18/813,882, 17/720,068, 63/619,241, 63/177,117, 63/580,137, 63/606,203, 63/562,335, US11948230B2), has been a consultant for Caristo Diagnostics Ltd and Ensight-AI Inc, and has received royalty fees from technology licensed through the University of Oxford, outside the submitted work.
-
Aug 14, 2024 | 
heart.bmj.com | Rohan Khera
Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. ElectrocardiographyDiagnostic ImagingA hundred years ago, in 1924, Willem Einthoven won the Nobel Prize for Physiology and Medicine for his invention of electrocardiography.
-
Jul 24, 2024 | 
heart.bmj.com | Rohan Khera
Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. ElectrocardiographyDiagnostic ImagingA hundred years ago, in 1924, Willem Einthoven won the Nobel Prize for Physiology and Medicine for his invention of electrocardiography.
-
Jul 2, 2024 | 
jacc.org | Rohan Khera |Evangelos Oikonomou |Girish N. Nadkarni |Jessica Morley
IntroductionArtificial intelligence (AI) is poised to transform every facet of cardiovascular practice and research.
-
Mar 4, 2024 | 
medrxiv.org | Arya Aminorroaya |Lovedeep Singh Dhingra |Evangelos Oikonomou |Rohan Khera
Dr. Khera is an Associate Editor at JAMA and receives research grant support, through Yale, from Bristol Myers Squibb, Novo Nordisk, and BridgeBio. He is a coinventor of U.S. Pending Patent Applications 63/619,241, 63/606,203, 63/177,117, 63/346,610, 63/428,569, and 63/484,426, unrelated to the current work. He receives support from the Blavatnik Foundation through the Blavatnik Fund for Innovation at Yale.
-
Dec 19, 2023 | 
jamanetwork.com | Rohan Khera |Melissa A. Simon |Mélissa Simon |Joseph S. Ross
Automation Bias and Assistive AI: Risk of Harm From AI-Driven Clinical Decision Support At the point of care, artificial intelligence (AI) algorithms have been developed to augment diagnostic decisions and suggest appropriate care pathways,1 by leveraging complex information in a patient’s electronic health record, such as imaging, documentation, and diagnostic testing.
-
Nov 1, 2023 | 
jamanetwork.com | Rebecca Voelker |Yulin Hswen |Rohan Khera |Atul J. Butte
This conversation is part of a series of interviews in which JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and expert guests explore issues surrounding the rapidly evolving intersection of artificial intelligence (AI) and medicine. AI and medicine intersect on a rapidly changing terrain where the possibilities are tremendous—tools that aid in the early detection of sepsis, for example, or help streamline transitions of care.
-
Aug 11, 2023 | 
jamanetwork.com | Rohan Khera |Michael Berkwits |Annette Flanagin
AI in Medicine—JAMA’s Focus on Clinical Outcomes, Patient-Centered Care, Quality, and Equity The transformative role of artificial intelligence (AI) in health care has been forecast for decades,1 but only recently have technological advances appeared to capture some of the complexity of health and disease and how health care is delivered.2 Recent emergence of large language models (LLMs) in highly visible and interactive applications3 has ignited interest in how new AI technologies can...
-
Apr 25, 2023 | 
jwatch.org | Rohan Khera |Allan S. Brett
Rohan Khera, MD, MS and Allan S. Brett, MDAuthors describe potential use of this artificial intelligence tool to create notes in the medical record and to provide curbside consultation. Increasingly, the medical literature is addressing the many ways in which artificial intelligence could enhance the quality of clinical practice. One artificial intelligence tool that has been publicized widely is ChatGPT, the online chatting interface.
-
Mar 24, 2023 | 
jwatch.org | Rohan Khera
Rohan Khera, MD, MS, reviewing In a meta-analysis of clinical trials, inflammation was a stronger marker of risk than LDL cholesterol in statin-treated individuals.
